Royal Fund Management’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Royal Fund Management’s Portfolio CSLT Stock Details CSLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-200	Closed	–	–	532
2017 Q1	$0	Hold	200	–	–	﹤0.01%	492
2016 Q4	$0	Buy	+200	New	+$906	﹤0.01%	419

Other funds holding CSLT

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

Royal Fund Management's CSLT Position: Q2 2017 in Review

Royal Fund Management sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q2 2017, closing a stake of 200 shares.

Royal Fund Management first reported a position in CSLT in Q4 2016 and held it in 2 quarters. The position peaked at $0 in Q1 2017. 84 funds tracked by Wall St. Rank hold CSLT as of Q2 2017.

Royal Fund Management reported no remaining CASTLIGHT HEALTH, INC. position as of Q2 2017 after selling out during the quarter.
Royal Fund Management sold 200 CASTLIGHT HEALTH, INC. shares in Q2 2017.
Royal Fund Management first reported a position in CASTLIGHT HEALTH, INC. in Q4 2016 and held it in 2 quarters.
Royal Fund Management's CASTLIGHT HEALTH, INC. position peaked at $0 in Q1 2017.
84 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q2 2017.

Based on Royal Fund Management's 13F filing for Q2 2017, filed 7 May 2020.